2019 Q1 Form 10-K Financial Statement

#000139047819000017 Filed on March 22, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.500M $2.640M $12.77M
YoY Change -35.57% -55.93% -15.36%
% of Gross Profit
Research & Development $1.859M $3.650M $8.767M
YoY Change 3.05% 414.08% 44.5%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $4.359M $6.290M $21.54M
YoY Change -23.31% -26.69% 1.81%
Operating Profit
YoY Change
Interest Expense $10.00K $30.00K -$270.0K
YoY Change -110.0% -100.5% -41.3%
% of Operating Profit
Other Income/Expense, Net -$190.0K $950.0K -$29.05M
YoY Change -91.44% 427.78% 23.6%
Pretax Income -$4.540M -$14.86M -$29.05M
YoY Change -43.25% 87.63% 23.6%
Income Tax -$1.540M -$1.378M
% Of Pretax Income
Net Earnings -$4.537M -$13.32M -$27.67M
YoY Change -43.25% -645.9% 16.49%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$10.09M -$30.27M -$106.4M
COMMON SHARES
Basic Shares Outstanding 23.18M shares 22.03M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.600M $5.300M $5.340M
YoY Change -25.71% 130.43% 130.17%
Cash & Equivalents $2.600M $5.337M $5.340M
Short-Term Investments
Other Short-Term Assets $800.0K $500.0K $500.0K
YoY Change -91.67% -95.33% -95.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.416M $5.838M $5.840M
YoY Change -73.87% -55.39% -55.39%
LONG-TERM ASSETS
Property, Plant & Equipment $500.0K
YoY Change
Goodwill $1.914M $1.900M
YoY Change 0.0% -0.73%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $600.0K $700.0K $660.0K
YoY Change -33.33% -22.22% -29.03%
Total Long-Term Assets $11.51M $11.08M $11.08M
YoY Change -43.61% -45.8% -45.79%
TOTAL ASSETS
Total Short-Term Assets $3.416M $5.838M $5.840M
Total Long-Term Assets $11.51M $11.08M $11.08M
Total Assets $14.93M $16.92M $16.92M
YoY Change -55.42% -49.55% -49.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.638M $3.755M $3.760M
YoY Change -59.5% -67.88% -67.84%
Accrued Expenses $807.0K $2.219M $2.070M
YoY Change -81.95% -30.68% -25.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $5.804M $5.974M $5.970M
YoY Change -77.46% -75.68% -75.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $5.800M $5.300M $5.340M
YoY Change -6.45% 103.85% 105.38%
Total Long-Term Liabilities $5.800M $0.00 $5.340M
YoY Change 404.35% -100.0% 2.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.804M $5.974M $5.970M
Total Long-Term Liabilities $5.800M $0.00 $5.340M
Total Liabilities $11.98M $11.67M $11.67M
YoY Change -65.59% -62.9% -62.91%
SHAREHOLDERS EQUITY
Retained Earnings -$86.39M -$81.86M
YoY Change 38.94% 51.07%
Common Stock $89.34M $87.10M
YoY Change 46.79% 54.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.950M $5.245M $5.250M
YoY Change
Total Liabilities & Shareholders Equity $14.93M $16.92M $16.92M
YoY Change -55.42% -49.55% -49.54%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$4.537M -$13.32M -$27.67M
YoY Change -43.25% -645.9% 16.49%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$4.991M -$4.550M -$30.42M
YoY Change -7.63% 161.49% 176.84%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid $487.0K
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $21.56M
YoY Change 258.98%
Debt Paid & Issued, Net $0.00 $7.601M
YoY Change -100.0% 1506.98%
Cash From Financing Activities $2.230M -80.00K $23.12M
YoY Change -52.94% -33.33% 317.84%
NET CHANGE
Cash From Operating Activities -$4.991M -4.550M -$30.42M
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities $2.230M -80.00K $23.12M
Net Change In Cash -$2.761M -4.630M -$7.299M
YoY Change 315.81% -144.95% -208.89%
FREE CASH FLOW
Cash From Operating Activities -$4.991M -$4.550M -$30.42M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001390478
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23176475 shares
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
14425577 USD
CY2018 dei Entity Registrant Name
EntityRegistrantName
SELLAS Life Sciences Group, Inc.
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Trading Symbol
TradingSymbol
SLS
CY2017Q4 gale Accrued Compensation Incentive
AccruedCompensationIncentive
100000 USD
CY2017 gale Adjustments To Additional Paid In Capital Deemed Dividend On Debt Conversion
AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnDebtConversion
-675000 USD
CY2017 gale Adjustments To Additional Paid In Capital Stock Options Exercised In Connection With Acquisition
AdjustmentsToAdditionalPaidInCapitalStockOptionsExercisedInConnectionWithAcquisition
32000 USD
CY2017Q4 gale Business Combination Estimated Fair Value Of Stock Options Outstanding
BusinessCombinationEstimatedFairValueOfStockOptionsOutstanding
32000 USD
CY2017Q4 gale Business Combination Fair Value Of Shares Outstanding
BusinessCombinationFairValueOfSharesOutstanding
12487000 USD
CY2017 gale Business Combination Pro Forma Transaction Costs
BusinessCombinationProFormaTransactionCosts
8700000 USD
CY2017 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
0 USD
CY2018 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
5302000 USD
CY2017 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
0 USD
CY2018 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
-3032000 USD
CY2017 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
0 USD
CY2018 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
-3032000 USD
CY2018 gale Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
5300000 USD
CY2018Q3 gale Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prefunded
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPrefunded
0.0001
CY2018 gale Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
4050000 shares
CY2018 gale Classof Warrantor Right Canceled Or Expired
ClassofWarrantorRightCanceledOrExpired
542000 shares
CY2018 gale Classof Warrantor Right Granted
ClassofWarrantorRightGranted
21327000 shares
CY2018 gale Classof Warrantor Right Surrenderedand Canceledto Purchase Common Stock
ClassofWarrantorRightSurrenderedandCanceledtoPurchaseCommonStock
121667 shares
CY2017Q4 gale Classof Warrantor Right Term
ClassofWarrantorRightTerm
P5Y
CY2018Q3 gale Classof Warrantor Right Term
ClassofWarrantorRightTerm
P5Y
CY2018Q4 gale Closing Price Of Common Stock
ClosingPriceOfCommonStock
1.23
CY2016Q2 gale Collaboration Agreement Term
CollaborationAgreementTerm
P3Y
CY2018Q4 gale Common Stock Capital Shares Reserved For Future Issuance Of Employee Stock Purchase Plan
CommonStockCapitalSharesReservedForFutureIssuanceOfEmployeeStockPurchasePlan
115000 shares
CY2018 gale Common Stock Issued During The Period For Cancellation Of Warrants
CommonStockIssuedDuringThePeriodForCancellationOfWarrants
54613 shares
CY2018 gale Common Stock Shares Acquiredin Exchangefor Warrants
CommonStockSharesAcquiredinExchangeforWarrants
412667 shares
CY2018Q4 gale Consideration Exchanged Fair Value
ConsiderationExchangedFairValue
1200000 USD
CY2017Q4 gale Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
1294000 USD
CY2018Q4 gale Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
4326000 USD
CY2017Q4 gale Contract Research Payable
ContractResearchPayable
51000 USD
CY2018Q4 gale Contract Research Payable
ContractResearchPayable
858000 USD
CY2017 gale Conversionwith Series A Convertible Preferred Stock
ConversionwithSeriesAConvertiblePreferredStock
0 USD
CY2018 gale Conversionwith Series A Convertible Preferred Stock
ConversionwithSeriesAConvertiblePreferredStock
4436000 USD
CY2018 gale Convertible Preferred Stock Dividends
ConvertiblePreferredStockDividends
487000 USD
CY2018 gale Debt Instrument Redemption Principal Amount Redeemed
DebtInstrumentRedemptionPrincipalAmountRedeemed
2800000 USD
CY2018 gale Debt Instrument Redemption Principal Amount Redeemed Settled In Cash
DebtInstrumentRedemptionPrincipalAmountRedeemedSettledInCash
600000 USD
CY2018Q4 gale Debt Instrument Redemption Principal Amount Redeemed Shares
DebtInstrumentRedemptionPrincipalAmountRedeemedShares
659529 shares
CY2017 gale Deemed Dividend Associated With Conversion Of Note And Common Stock Warrant Issuance
DeemedDividendAssociatedWithConversionOfNoteAndCommonStockWarrantIssuance
675000 USD
CY2018 gale Deemed Dividend Associated With Conversion Of Note And Common Stock Warrant Issuance
DeemedDividendAssociatedWithConversionOfNoteAndCommonStockWarrantIssuance
0 USD
CY2017 gale Deemed Dividend On Debt Conversion
DeemedDividendOnDebtConversion
675000 USD
CY2018 gale Deemed Dividend On Debt Conversion
DeemedDividendOnDebtConversion
0 USD
CY2017Q4 gale Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
2105000 USD
CY2017 gale Fair Value Of Stock Options Assumed In Connection With Acquisition
FairValueOfStockOptionsAssumedInConnectionWithAcquisition
32000 USD
CY2018 gale Fair Value Of Stock Options Assumed In Connection With Acquisition
FairValueOfStockOptionsAssumedInConnectionWithAcquisition
0 USD
CY2018Q4 gale Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
5961000 USD
CY2018 gale Dividend Modification Of Warrants
DividendModificationOfWarrants
-491000 USD
CY2018 gale Dividend On Conversion Of Series A Convertible Preferred Stock
DividendOnConversionOfSeriesAConvertiblePreferredStock
4436000 USD
CY2017 gale Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation
DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation
0 USD
CY2018Q3 gale Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation
DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation
8700000 USD
CY2018 gale Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation
DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNation
8654000 USD
CY2017 gale Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.011
CY2018 gale Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.015
CY2018 gale Employee Service Share Based Compensation Unrecognized Compensation Costs
EmployeeServiceShareBasedCompensationUnrecognizedCompensationCosts
900000 USD
CY2018 gale Employee Service Share Based Compensation Unrecognized Compensation Costs Weighted Average Period Of Recognition
EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsWeightedAveragePeriodOfRecognition
P2Y1M17D
CY2017 gale Fair Value Of Parent Company Common Stock Issued In Exchange For Services
FairValueOfParentCompanyCommonStockIssuedInExchangeForServices
449000 USD
CY2018 gale Fair Value Of Parent Company Common Stock Issued In Exchange For Services
FairValueOfParentCompanyCommonStockIssuedInExchangeForServices
0 USD
CY2018 gale Fair Value Of Warrants Canceled
FairValueOfWarrantsCanceled
526000 USD
CY2018 gale Fair Value Of Warrants Exercise Price Adjustment
FairValueOfWarrantsExercisePriceAdjustment
491000 USD
CY2018 gale Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity
FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity
5530000 USD
CY2017Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
1309000 USD
CY2018Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
1013000 USD
CY2017Q4 gale Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
1309000 USD
CY2018Q4 gale Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
1013000 USD
CY2018 gale Fair Valueof Warrants Granted
FairValueofWarrantsGranted
5039000 USD
CY2017Q4 gale Fair Valueof Warrants Grantedper Share
FairValueofWarrantsGrantedperShare
5.60
CY2017Q4 gale Impact On Tax Provision From Unrecognized Tax Benefits
ImpactOnTaxProvisionFromUnrecognizedTaxBenefits
72000 USD
CY2018Q4 gale Impact On Tax Provision From Unrecognized Tax Benefits
ImpactOnTaxProvisionFromUnrecognizedTaxBenefits
55000 USD
CY2017Q4 gale In Process Research Development
InProcessResearchDevelopment
17600000 USD
CY2018Q4 gale In Process Research Development
InProcessResearchDevelopment
8500000 USD
CY2018 gale Incentive Fee Percentage Equal To Gross Value Paid By Purchaser In Cash
IncentiveFeePercentageEqualToGrossValuePaidByPurchaserInCash
0.02
CY2018Q4 gale Incentive Fee Percentage Equal To Post Money Market Value
IncentiveFeePercentageEqualToPostMoneyMarketValue
0.02
CY2017Q1 gale Incentive Fee Percentage Equal To Post Money Market Value
IncentiveFeePercentageEqualToPostMoneyMarketValue
0.02
CY2017 gale Increase Decrease In Fair Value Of Warrant Liability
IncreaseDecreaseInFairValueOfWarrantLiability
0 USD
CY2018 gale Increase Decrease In Fair Value Of Warrant Liability
IncreaseDecreaseInFairValueOfWarrantLiability
491000 USD
CY2018 gale Increase Decrease In Fair Value Of Warrant Liability
IncreaseDecreaseInFairValueOfWarrantLiability
500000 USD
CY2017 gale Liability Classified Warrants Antidilution Protection
LiabilityClassifiedWarrantsAntidilutionProtection
0 USD
CY2018 gale Liability Classified Warrants Antidilution Protection
LiabilityClassifiedWarrantsAntidilutionProtection
491000 USD
CY2017 gale Litigation Settlement Issuanceof Common Stock Value
LitigationSettlementIssuanceofCommonStockValue
0 USD
CY2018 gale Litigation Settlement Issuanceof Common Stock Value
LitigationSettlementIssuanceofCommonStockValue
1250000 USD
CY2017 gale Longterm Debt Issued In Connection With Warrant Exchanges
LongtermDebtIssuedInConnectionWithWarrantExchanges
0 USD
CY2018 gale Longterm Debt Issued In Connection With Warrant Exchanges
LongtermDebtIssuedInConnectionWithWarrantExchanges
966000 USD
CY2017 gale Loss On Settlement Of Liability Classified Warrants
LossOnSettlementOfLiabilityClassifiedWarrants
0 USD
CY2018 gale Loss On Settlement Of Liability Classified Warrants
LossOnSettlementOfLiabilityClassifiedWarrants
727000 USD
CY2017 gale Loss On Settlement Of Warrants Liability
LossOnSettlementOfWarrantsLiability
0 USD
CY2018 gale Loss On Settlement Of Warrants Liability
LossOnSettlementOfWarrantsLiability
727000 USD
CY2018 gale Loss On Settlement Of Warrants Liability
LossOnSettlementOfWarrantsLiability
700000 USD
CY2018 gale Maximum Indefinitelived Deferred Tax Liability As Percentage Of Net Operating Loss
MaximumIndefinitelivedDeferredTaxLiabilityAsPercentageOfNetOperatingLoss
80
CY2018 gale Operating Loss And Tax Credit Carryforwards Limitations On Use Minimum Change In Ownership Percentage
OperatingLossAndTaxCreditCarryforwardsLimitationsOnUseMinimumChangeInOwnershipPercentage
0.5
CY2018Q4 gale Options Reserved For Future Issuance Under Companies Incentive Plan
OptionsReservedForFutureIssuanceUnderCompaniesIncentivePlan
421000 shares
CY2018 gale Percentage Increase In Number Of Shares Available For Future Issuance Under Stock Based Awards
PercentageIncreaseInNumberOfSharesAvailableForFutureIssuanceUnderStockBasedAwards
0.01
CY2018 gale Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
9647000 USD
CY2017Q4 gale Rebates And Returns Of Former Commercial Products
RebatesAndReturnsOfFormerCommercialProducts
223000 USD
CY2018Q4 gale Rebates And Returns Of Former Commercial Products
RebatesAndReturnsOfFormerCommercialProducts
138000 USD
CY2017 gale Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock
ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock
0 USD
CY2018 gale Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock
ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock
285000 USD
CY2017 gale Reclassification Of Warrant Liability Upon Exercise
ReclassificationOfWarrantLiabilityUponExercise
12487000 USD
CY2018 gale Reclassification Of Warrant Liability Upon Exercise
ReclassificationOfWarrantLiabilityUponExercise
0 USD
CY2018Q4 gale Restricted Stock Shares Reservedfor Future Issuance
RestrictedStockSharesReservedforFutureIssuance
13000 shares
CY2018 gale Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue
0 USD
CY2018 gale Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateAggregateIntrinsicValue
0 USD
CY2017 gale Share Based Compensation Arrangement By Share Based Payment Award Percentage Earning Of Participants
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageEarningOfParticipants
0.15
CY2017 gale Shares And Common Stock Warrants Issued Upon Conversion Of Notes During Period
SharesAndCommonStockWarrantsIssuedUponConversionOfNotesDuringPeriod
6739000 USD
CY2017 gale Shares Issued To Settle Accounts Payable
SharesIssuedToSettleAccountsPayable
150000 USD
CY2018 gale Shares Issued To Settle Accounts Payable
SharesIssuedToSettleAccountsPayable
0 USD
CY2017 gale Shares Issued To Settler Related Party Accounts Payable
SharesIssuedToSettlerRelatedPartyAccountsPayable
228000 USD
CY2018 gale Shares Issued To Settler Related Party Accounts Payable
SharesIssuedToSettlerRelatedPartyAccountsPayable
0 USD
CY2014Q3 gale Shares Issued Under License Agreement
SharesIssuedUnderLicenseAgreement
13199 shares
CY2017Q2 gale Shares Issued Under License Agreement
SharesIssuedUnderLicenseAgreement
8799 shares
CY2017 gale Stock Issued During Period Value Settlement Of Related Party Accounts Payable
StockIssuedDuringPeriodValueSettlementOfRelatedPartyAccountsPayable
378000 USD
CY2017 gale Stock Issued For Antidilution Provisions
StockIssuedForAntidilutionProvisions
61000 USD
CY2017 gale Stock Issued For Incentive Fee Payment In Connection With Acquisition During Period
StockIssuedForIncentiveFeePaymentInConnectionWithAcquisitionDuringPeriod
900000 USD
CY2017 gale Stock Issued For Incentive Fee Payment In Connection With Acquisition During Period
StockIssuedForIncentiveFeePaymentInConnectionWithAcquisitionDuringPeriod
941000 USD
CY2017Q4 gale Stock Issued For Incentive Fee Payment In Connection With Acquisition During Period Share
StockIssuedForIncentiveFeePaymentInConnectionWithAcquisitionDuringPeriodShare
119672 shares
CY2017 gale Stock Issued For Incentive Fee Payment In Connection With Acquisition During Period Shares
StockIssuedForIncentiveFeePaymentInConnectionWithAcquisitionDuringPeriodShares
119672 shares
CY2017 gale Stock Issued In Connection With Amendments To License During Period Value
StockIssuedInConnectionWithAmendmentsToLicenseDuringPeriodValue
388000 USD
CY2017 gale Success Fee And Other Transaction Costs
SuccessFeeAndOtherTransactionCosts
4800000 USD
CY2018 gale Warrant Exchange Agreements Amount
WarrantExchangeAgreementsAmount
285000 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
6000000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11691000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3755000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3201000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2219000 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1744000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
540000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56254000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
87098000 USD
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
258000 USD
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-4436000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3169000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
395000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5039000 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3169000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
395000 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1883000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
986000 shares
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18106000 shares
CY2017Q4 us-gaap Assets
Assets
33526000 USD
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17698000 shares
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Assets
Assets
16915000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
13087000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
5838000 USD
CY2017 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
5.15
CY2017Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
5.15
CY2017 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-24089000 USD
CY2017Q4 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
12519000 USD
CY2017Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
17600000 USD
CY2018Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
8500000 USD
CY2017 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
12158000 USD
CY2018 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2319000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5300000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5337000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6047000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12750000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5451000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6703000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7299000 USD
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.42
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.59
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.10
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
316163 shares
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
11520000 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
963000 shares
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18642000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5766891 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22026476 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5766891 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22026476 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5766891 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2017 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2018 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
3721000 USD
CY2018Q3 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
7871186 USD
CY2018Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
3748184 shares
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12838000 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1428000 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1765000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-570000 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6423000 USD
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
23039000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
31089000 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
76000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-106000 USD
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
214000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-61000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
138000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
45000 USD
CY2017Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
10200000 USD
CY2017Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
10988000 USD
CY2018 us-gaap Decrease In Restricted Cash
DecreaseInRestrictedCash
1800000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-747000 USD
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
39000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1317000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3438000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1785000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1673000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
357000 USD
CY2018 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1316000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
39000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1765000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1428000 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1028000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4464000 USD
CY2017Q4 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
395000 USD
CY2018Q4 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
56000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
345000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
134000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2550000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2223000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4658000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11410000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1673000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
357000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
3438000 USD
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5300000 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
766000 USD
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
900000 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.004
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.010
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.014
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.005
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
566000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
675000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1785000 USD
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
925000 USD
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
663000 USD
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-10.44
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.15
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.047
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.235
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.139
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.344
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.086
CY2017Q4 us-gaap Goodwill
Goodwill
1900000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
1914000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
1900000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
1914000 USD
CY2017 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2018 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9550000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
265000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17179000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23501000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29048000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-23766000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-11869000 USD
CY2017 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-23754000 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-27670000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
253000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1400000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1378000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8366000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7936000 USD
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2374000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2282000 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-73000 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-212000 USD
CY2017 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-462000 USD
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-266000 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
321000 USD
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
941000 USD
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200000 USD
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
31456000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
11670000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33526000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16915000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24569000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5974000 USD
CY2017Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1300000 USD
CY2018Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8377000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2611000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2017 us-gaap Management Fee Expense
ManagementFeeExpense
300000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5534000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23123000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12158000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10989000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30422000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-23754000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-27670000 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24429000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41251000 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23501000 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29048000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
601000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
377000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
224000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
191000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8000 USD
CY2017 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
CY2018 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
9100000 USD
CY2017 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-462000 USD
CY2018 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2041000 USD
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2018 us-gaap Paid In Kind Interest
PaidInKindInterest
134000 USD
CY2016Q2 us-gaap Payment For Management Fee
PaymentForManagementFee
100000 USD
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
487000 USD
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4436000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
337000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
387000 USD
CY2018Q4 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
500000 USD
CY2017 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
0 USD
CY2018 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
186000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6007000 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21564000 USD
CY2017 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
0 USD
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
9647000 USD
CY2017 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
5200000 USD
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
473000 USD
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7601000 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6067000 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8767000 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10431000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
114000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54185000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81855000 USD
CY2018Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
21600000 USD
CY2018Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.10
CY2018Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.10
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15089000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12772000 USD
CY2017 us-gaap Severance Costs1
SeveranceCosts1
1883000 USD
CY2017 us-gaap Severance Costs1
SeveranceCosts1
1900000 USD
CY2018 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3169000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
395000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8083
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0273
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
53000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
241.17
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
98000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
483000 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.73
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10000 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
395000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1240.55
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.09
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.30
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.24
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y7M17D
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y0M4D
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P10Y
CY2017 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
12487000 USD
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1294000 USD
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6007000 USD
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21564000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2070000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5245000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4997000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2070000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5245000 USD
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
426000 USD
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
55000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
17000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
28000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
44000 USD
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1400000 USD
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2340368 shares
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13077140 shares
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions, the balances of which frequently exceed federally insured limits.</font></div></div>
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">On an ongoing basis, the Company evaluates its estimates using historical experience and other factors, including the current economic environment. Significant items subject to such estimates are assumptions used for purposes of determining stock-based compensation, the fair value of the warrants, beneficial conversion features associated with convertible notes, fair value of intangible assets acquired, carrying value of goodwill, fair value of contingent purchase price consideration, fair value of deferred tax liability assumed and accounting for research and development activities. Management believes its estimates to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001390478-19-000017-index-headers.html Edgar Link pending
0001390478-19-000017-index.html Edgar Link pending
0001390478-19-000017.txt Edgar Link pending
0001390478-19-000017-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gale-20181231.xml Edgar Link completed
gale-20181231.xsd Edgar Link pending
gale-20181231_cal.xml Edgar Link unprocessable
gale-20181231_def.xml Edgar Link unprocessable
gale-20181231_lab.xml Edgar Link unprocessable
gale-20181231_pre.xml Edgar Link unprocessable
gpsinamlincr2studyschemarevi.jpg Edgar Link pending
gpsmoa.jpg Edgar Link pending
mrkcombotrialfeaturesandsche.jpg Edgar Link pending
pipeline03152019.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sellas-logoa05.jpg Edgar Link pending
Show.js Edgar Link pending
sls-20181231x10k.htm Edgar Link pending
sls20181231ex231.htm Edgar Link pending
sls20181231ex311.htm Edgar Link pending
sls20181231ex312.htm Edgar Link pending
sls20181231ex321.htm Edgar Link pending
wt1cancersa01.jpg Edgar Link pending